108 related articles for article (PubMed ID: 29498405)
41. High expression of protein phosphatase 4 is associated with the aggressive malignant behavior of colorectal carcinoma.
Li X; Liang L; Huang L; Ma X; Li D; Cai S
Mol Cancer; 2015 Apr; 14():95. PubMed ID: 25927939
[TBL] [Abstract][Full Text] [Related]
42. PDGFRα/β and VEGFR2 polymorphisms in colorectal cancer: incidence and implications in clinical outcome.
Estevez-Garcia P; Castaño A; Martin AC; Lopez-Rios F; Iglesias J; Muñoz-Galván S; Lopez-Calderero I; Molina-Pinelo S; Pastor MD; Carnero A; Paz-Ares L; Garcia-Carbonero R
BMC Cancer; 2012 Nov; 12():514. PubMed ID: 23146028
[TBL] [Abstract][Full Text] [Related]
43. The acid-sensing ion channel, ASIC2, promotes invasion and metastasis of colorectal cancer under acidosis by activating the calcineurin/NFAT1 axis.
Zhou ZH; Song JW; Li W; Liu X; Cao L; Wan LM; Tan YX; Ji SP; Liang YM; Gong F
J Exp Clin Cancer Res; 2017 Sep; 36(1):130. PubMed ID: 28927426
[TBL] [Abstract][Full Text] [Related]
44. Combinational treatment with microRNA‑133b and cetuximab has increased inhibitory effects on the growth and invasion of colorectal cancer cells by regulating EGFR.
Zhou J; Lv L; Lin C; Hu G; Guo Y; Wu M; Tian B; Li X
Mol Med Rep; 2015 Oct; 12(4):5407-14. PubMed ID: 26151111
[TBL] [Abstract][Full Text] [Related]
45. Role of SMC1A overexpression as a predictor of poor prognosis in late stage colorectal cancer.
Wang J; Yu S; Cui L; Wang W; Li J; Wang K; Lao X
BMC Cancer; 2015 Mar; 15():90. PubMed ID: 25884313
[TBL] [Abstract][Full Text] [Related]
46. Expression of the hMLH1 gene is a possible predictor for the clinical response to 5-fluorouracil after a surgical resection in colorectal cancer.
Ide T; Kitajima Y; Ohtaka K; Mitsuno M; Nakafusa Y; Miyazaki K
Oncol Rep; 2008 Jun; 19(6):1571-6. PubMed ID: 18497967
[TBL] [Abstract][Full Text] [Related]
47. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
[TBL] [Abstract][Full Text] [Related]
48. Distinct roles and differential expression levels of Wnt5a mRNA isoforms in colorectal cancer cells.
Huang TC; Lee PT; Wu MH; Huang CC; Ko CY; Lee YC; Lin DY; Cheng YW; Lee KH
PLoS One; 2017; 12(8):e0181034. PubMed ID: 28859077
[TBL] [Abstract][Full Text] [Related]
49. UbcH10 expression can predict prognosis and sensitivity to the antineoplastic treatment for colorectal cancer patients.
Cacciola NA; Calabrese C; Malapelle U; Pellino G; De Stefano A; Sepe R; Sgariglia R; Quintavalle C; Federico A; Bianco A; Uchimura Bastos A; Milone M; Bellevicine C; Milone F; Carlomagno C; Selvaggi F; Troncone G; Fusco A; Pallante P
Mol Carcinog; 2016 May; 55(5):793-807. PubMed ID: 25917796
[TBL] [Abstract][Full Text] [Related]
50. TACC3 promotes colorectal cancer tumourigenesis and correlates with poor prognosis.
Du Y; Liu L; Wang C; Kuang B; Yan S; Zhou A; Wen C; Chen J; Wu Y; Yang X; Feng G; Liu B; Iwamoto A; Zeng M; Wang J; Zhang X; Liu H
Oncotarget; 2016 Jul; 7(27):41885-41897. PubMed ID: 27248823
[TBL] [Abstract][Full Text] [Related]
51. Aptamer targeting EGFRvIII mutant hampers its constitutive autophosphorylation and affects migration, invasion and proliferation of glioblastoma cells.
Camorani S; Crescenzi E; Colecchia D; Carpentieri A; Amoresano A; Fedele M; Chiariello M; Cerchia L
Oncotarget; 2015 Nov; 6(35):37570-87. PubMed ID: 26461476
[TBL] [Abstract][Full Text] [Related]
52. Heat shock protein 70-2 (HSP70-2) is a novel therapeutic target for colorectal cancer and is associated with tumor growth.
Jagadish N; Parashar D; Gupta N; Agarwal S; Suri V; Kumar R; Suri V; Sadasukhi TC; Gupta A; Ansari AS; Lohiya NK; Suri A
BMC Cancer; 2016 Jul; 16():561. PubMed ID: 27473057
[TBL] [Abstract][Full Text] [Related]
53. Downregulation of LncRNA-RP11-317J10.2 promotes cell proliferation and invasion and predicts poor prognosis in colorectal cancer.
Luo J; Xu LN; Zhang SJ; Jiang YG; Zhuo DX; Wu LH; Jiang X; Huang Y
Scand J Gastroenterol; 2018 Jan; 53(1):38-45. PubMed ID: 29073791
[TBL] [Abstract][Full Text] [Related]
54. Expression of CLDN1 in colorectal cancer: a novel marker for prognosis.
Nakagawa S; Miyoshi N; Ishii H; Mimori K; Tanaka F; Sekimoto M; Doki Y; Mori M
Int J Oncol; 2011 Oct; 39(4):791-6. PubMed ID: 21720707
[TBL] [Abstract][Full Text] [Related]
55. Overexpression of BIRC6 Is a Predictor of Prognosis for Colorectal Cancer.
Hu T; Weng S; Tang W; Xue R; Chen S; Cai G; Cai Y; Shen X; Zhang S; Dong L
PLoS One; 2015; 10(5):e0125281. PubMed ID: 25933218
[TBL] [Abstract][Full Text] [Related]
56. DcR3 induces epithelial-mesenchymal transition through activation of the TGF-β3/SMAD signaling pathway in CRC.
Liu YP; Zhu HF; Liu DL; Hu ZY; Li SN; Kan HP; Wang XY; Li ZG
Oncotarget; 2016 Nov; 7(47):77306-77318. PubMed ID: 27764793
[TBL] [Abstract][Full Text] [Related]
57. Octamer transcription factor 1 mediates epithelial-mesenchymal transition in colorectal cancer.
Li Y; Dong M; Kong F; Zhou J
Tumour Biol; 2015 Dec; 36(12):9941-6. PubMed ID: 26178483
[TBL] [Abstract][Full Text] [Related]
58. Jumonji domain containing 1A is a novel prognostic marker for colorectal cancer: in vivo identification from hypoxic tumor cells.
Uemura M; Yamamoto H; Takemasa I; Mimori K; Hemmi H; Mizushima T; Ikeda M; Sekimoto M; Matsuura N; Doki Y; Mori M
Clin Cancer Res; 2010 Sep; 16(18):4636-46. PubMed ID: 20823141
[TBL] [Abstract][Full Text] [Related]
59. Hypomethylation-associated up-regulation of TCF3 expression and recurrence in stage II and III colorectal cancer.
Li C; Cai S; Wang X; Jiang Z
PLoS One; 2014; 9(11):e112005. PubMed ID: 25375219
[TBL] [Abstract][Full Text] [Related]
60. Clinical Significance of Methylation and Reduced Expression of the Quaking Gene in Colorectal Cancer.
Iwata N; Ishikawa T; Okazaki S; Mogushi K; Baba H; Ishiguro M; Kobayashi H; Tanaka H; Kawano T; Sugihara K; Uetake H
Anticancer Res; 2017 Feb; 37(2):489-498. PubMed ID: 28179294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]